WCN26-7612 EFFECT OF HIGH DOSE HAEMODIAFILTRATION VERSUS HIGH FLUX HAEMODIALYSIS ON MORTALITY: A TARGET TRIAL EMULATION UTILISING THE ANZDATA REGISTRY

Read full text Summarise with VIRAT
Authors: Su Jen Chua, Leanne Brown, Lukas Kairatis, Rathika Krishnasamy, Emily J. See, David John Semple, Nigel David Toussaint, Andrea Katharina Viecelli, Eric Hoi Kit Au, Dana S. Forcey, Jayson Catiwa, Kevan Roy Polkinghorne
+1 more Matthew A. Roberts
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The CONVINCE trial was a multinational, pragmatic, open-label, randomised controlled trial designed to evaluate benefits and harms of high-dose post-dilution haemodiafiltration (HDF) (convection volume ≥23 litres/1.73m2) compared with conventional high-flux haemodialysis (HD). The trial reported all-cause mortality benefit in patients undergoing HDF, however controversy exists regarding the entry criterion which may have selected a relatively healthier population, leading to results possibly not generalisable to the wider dialysis population.

Fields of Study & Subjects

Dialysis and Renal Disease Management Acute Kidney Injury Research Central Venous Catheters and Hemodialysis

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105321–105321
Publication date
25 March 2026
Language
EN